Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipidemia

被引：6
|
作者：
Kostapanos, Michael S. [1 ,2 ]
Elisaf, Moses S. [2 ]
Mikhailidis, Dimitri P. [1 ]
机构：
[1] UCL, Sch Med, Dept Clin Biochem, London NW3 2QG, England
[2] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 2012年 / 17卷 / 04期
关键词：
PRIMARY DYSLIPIDEMIA; EZETIMIBE; STATEMENT; STATIN; PANEL;
D O I：
10.1177/1074248412443424
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 427
页数：1
相关论文
共 50 条
  • [1] Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipedemia
    Lee, Sang-Hak
    Park, Sungha
    Kang, Seok-Min
    Jang, Yangsoo
    Chung, Namsik
    Choi, Donghoon
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (01) : 65 - 71
  • [2] Response to Letter on "Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipedemia"
    Lee, Sang-Hak
    Choi, Donghoon
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (04) : 428 - 428
  • [3] Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia
    Chatley, P.
    Badyal, D. K.
    Calton, R.
    Khosla, P. P.
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2007, 29 (03): : 217 - 221
  • [4] Effects of atorvastatin on fasting and postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidemia
    Boquist, S
    Karpe, F
    Danell-Toverud, K
    Hamsten, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 315A - 315A
  • [5] Effect of low dose of atorvastatin on hyperhomocysteinemic patients with associated combined hyperlipidemia
    Díaz-Peromingo, JA
    Albán-Salgado, A
    Sánchez-Leira, J
    García-Suárez, F
    Padín-Paz, E
    Saborido-Froján, J
    Iglesias-Gallego, M
    Fernández-Ameneiros, MJ
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 105 - 106
  • [6] Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia
    Verseyden, C
    Meijssen, S
    van Dijk, H
    Jansen, H
    Cabezas, MC
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (11) : 2100 - 2108
  • [7] Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia
    Avisar, Inbal
    Brook, J. Gerald
    Wolfovitz, Efrat
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (03) : 203 - 208
  • [8] Multiparticulate Systems of Ezetimibe Micellar System and Atorvastatin Solid Dispersion Efficacy of Low-Dose Ezetimibe/Atorvastatin on High-Fat Diet-Induced Hyperlipidemia and Hepatic Steatosis in Diabetic Rats
    Torrado-Salmeron, Carlos
    Guarnizo-Herrero, Victor
    Henriques, Joana
    Seica, Raquel
    Sena, Cristina M.
    Torrado-Santiago, Santiago
    [J]. PHARMACEUTICS, 2021, 13 (03)
  • [9] Effect of Combination Therapy of Ezetimibe and Atorvastatin on Remnant Lipoprotein Versus Double Atorvastatin Dose in Egyptian Diabetic Patients
    El-Tamalawy, Mona Mohammed
    Ibrahim, Osama Mohamed
    Hassan, Timour Mostafa
    El-Barbari, Ali Ali
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (01): : 34 - 41
  • [10] COMPARISON OF THE COMBINED EFFECT OF ATORVASTATIN/DIOSGENIN VS ATORVASTATIN/EZETIMIBE ON HYPERCHOLESTEROLEMIC RATS
    Diaz, J.
    Juarez, I.
    Ble, J.
    Rodriguez, A.
    Ruiz, G.
    Marin, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345